Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Atopaxar, a reversible PAR-1 thrombin receptor antagonist, interferes with platelet signaling. Atopaxar has been investigated for the treatment of Coronary Artery Disease and Acute Coronary Syndrome.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | In stock | $ 1,370.00 | |
50 mg | In stock | $ 1,780.00 |
Description | Atopaxar, a reversible PAR-1 thrombin receptor antagonist, interferes with platelet signaling. Atopaxar has been investigated for the treatment of Coronary Artery Disease and Acute Coronary Syndrome. |
Molecular Weight | 608.54 |
Formula | C29H39BrFN3O5 |
CAS No. | 474550-69-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 10 mM
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Atopaxar Hydrobromide 474550-69-1 GPCR/G Protein Protease-activated Receptor receptor receptor-1 E5555 protease-activated Atopaxar E 5555 ER 172594-06 inhibit E-5555 Thrombin receptors platelets PAR-1 Protease Activated Receptor (PAR) atherothrombotic thrombin Inhibitor signaling inhibitor